Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection

To fight tuberculosis, better vaccination strategies are needed. Live attenuated Mycobacterium tuberculosis-derived vaccine, MTBVAC, is a promising candidate in the pipeline, proven to be safe and immunogenic in humans so far. Independent studies have shown that pulmonary mucosal delivery of Bacillu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cell Rep Med
Auteurs principaux: Dijkman, Karin, Aguilo, Nacho, Boot, Charelle, Hofman, Sam O., Sombroek, Claudia C., Vervenne, Richard A.W., Kocken, Clemens H.M., Marinova, Dessislava, Thole, Jelle, Rodríguez, Esteban, Vierboom, Michel P.M., Haanstra, Krista G., Puentes, Eugenia, Martin, Carlos, Verreck, Frank A.W.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817873/
https://ncbi.nlm.nih.gov/pubmed/33521701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100187
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires